SCHEMBL16264141

SCHEMBL16264141

CCC(=O)N(CCC(C)=O)CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
SLC15A2 Q16348 1/20 0.39
ALDH1A1 P00352 4/20 0.35
ALDH2 P05091 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
FFAR3 O14843 2/20 0.35
EYA2 O00167 1/20 0.34
APP P05067 1/20 0.34
ACE P12821 1/20 0.34
KDM4E B2RXH2 2/20 0.33
CHRM2 P08172 1/20 0.33
ADRA2A P08913 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
CYP2C19 P33261 1/20 0.33
ADRA1A P35348 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16264142 0.81 TDP1 (0.39) LMNASLC15A2ALDH1A1TDP1FFAR3
SCHEMBL5080836 0.81 CA12 (0.43) LMNAALDH1A1TDP1FFAR3EYA2
SCHEMBL14749727 0.81 PAOX (0.41) LMNASLC15A2PHF8KDM2A
SCHEMBL14749726 0.81 PAOX (0.41) LMNASLC15A2PHF8KDM2A
SCHEMBL14749722 0.81 PAOX (0.41) LMNASLC15A2PHF8KDM2A
SCHEMBL6444629 0.80 FFAR3 (0.47) LMNAALDH1A1TDP1FFAR3EYA2
SCHEMBL12287388 0.79 TSHR (0.43) LMNAALDH1A1TDP1ALOX15TSHR
SCHEMBL12287737 0.79 TSHR (0.43) LMNAALDH1A1TDP1ALOX15TSHR
SCHEMBL12287396 0.79 TSHR (0.43) LMNAALDH1A1TDP1ALOX15TSHR
SCHEMBL8602002 0.78 FFAR3 (0.45) LMNAALDH1A1TDP1FFAR3EYA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140350217-A1 FUNCTIONAL LIPID CONSTRUCTS KODE BIOTECH LIMITED (NZ) 2014-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350217-A1 FUNCTIONAL LIPID CONSTRUCTS CETP, LCAT, SGMS1 LMNA 1884/4885SLC15A2 1138/4885ALDH1A1 2075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.